zodasiran
Sponsor Arrowhead Pharmaceuticals, INC. · listed as ARWR
READOUT
Phase 3
Confidence: medium
Source: clinicaltrials
Next catalyst
Event typeREADOUT
Expected date2027-08-20
As disclosedAug 20, 2027
Date precisionday
Confidencemedium
Trial & sponsor
Trial (NCT)NCT07037771
PhasePHASE3
StatusRECRUITING
Lead sponsorArrowhead Pharmaceuticals
Listed asARWR
Condition(s)Homozygous Familial Hypercholesterolemia
!
Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.
This is one row of the free CSA sample. The full snapshot carries 2,103 forward catalysts across 139 listed sponsors.
Get the full dataset — $499 → More ARWR catalysts